CB

CBAK Energy Technology Limited

CBATIndustrialsNASDAQ

Electrical Equipment & Parts · Last scanned Sep 9, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$195.2M
+10.5% YoY
Net Income
-$9.4M
-179.5% YoY
EBITDA
-$8.1M
-143.0% YoY
Free Cash Flow
$38.7M

Scan Results

Daily timeframe
2 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 RSI OverboughtRSI 71.7, above 70, stock may be overbought
Aug 27 RSI OverboughtRSI 78.8, above 70, stock may be overbought
About CBAK Energy Technology Limited

CBAK Energy Technology Limited, together with its subsidiaries, manufactures, commercializes, and distributes lithium-ion and sodium-ion rechargeable batteries. Valued at $88.6M, CBAT is a micro-cap name in its sector. The company operates through the CBAK and Hitrans segments.

Where CBAT stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, CBAT finished 28.21% above its 150-day moving average ($0.78) and 25.00% above its 200-day moving average ($0.80). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CBAT overbought or oversold?

At the September 3, 2026 close, CBAT's RSI(14) was 71.7, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$88.6M
Fwd P/E3.03
EPS$-0.18
Beta1.50
52W Change+8.9%
ROE-16.2%
Analysis

CBAK Energy Technology Limited carries $51.0M in total debt against $9.4M in cash reserves — debt is roughly 5.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $38.7M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -16.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $248.7M (2022) to $195.2M (2025), a 22% decline worth watching.

The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. No single metric tells the full story. Reviewing CBAT's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Industrials stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms